Pages that link to "Q33341695"

The following pages link to Genetic susceptibility to type 1 diabetes (Q33341695):

Displaying 47 items.

• M19 modulates skeletal muscle differentiation and insulin secretion in pancreatic β-cells through modulation of respiratory chain activity (Q24306087) (← links)
• Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant (Q24317388) (← links)
• Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity (Q24633643) (← links)
• Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden (Q24671765) (← links)
• Protein tyrosine phosphatase PTPN22 in human autoimmunity (Q28242744) (← links)
• Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes (Q30434071) (← links)
• The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice (Q30435990) (← links)
• Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases (Q33235613) (← links)
• Protein profiling of pancreatic islets (Q33267158) (← links)
• Association of insulin-like growth factor 2 with the insulin-linked polymorphic region in cultured fetal thymus cells (Q33480198) (← links)
• Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells (Q33556598) (← links)
• Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. (Q33854444) (← links)
• Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. (Q33869101) (← links)
• Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. (Q33869811) (← links)
• Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity (Q33918375) (← links)
• Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background (Q34142507) (← links)
• Genetic susceptibility to autoimmune liver disease (Q34560805) (← links)
• C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study (Q35404985) (← links)
• Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes (Q36718178) (← links)
• Regulation of type 1 diabetes by NKT cells. (Q36799687) (← links)
• Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). (Q36842573) (← links)
• Regulatory T cells control diabetes without compromising acute anti-viral defense (Q36957509) (← links)
• MerTK regulates thymic selection of autoreactive T cells (Q37140066) (← links)
• Latent (slowly progressing) autoimmune diabetes in adults (Q37150501) (← links)
• Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse. (Q37237062) (← links)
• Reduced IL‐2 expression in NOD mice leads to a temporal increase in CD62LloFoxP3+CD4+ T cells with limited suppressor activity (Q37248276) (← links)
• T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function (Q37320399) (← links)
• Dysrulation of T cell peripheral tolerance in type 1 diabetes (Q37359000) (← links)
• Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus. (Q37395299) (← links)
• Role of PD-L1 and PD-L2 in allergic diseases and asthma (Q37781079) (← links)
• Type 1 diabetes: etiology, immunology, and therapeutic strategies (Q37830198) (← links)
• Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes (Q38117283) (← links)
• Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children (Q39272852) (← links)
• Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond? (Q40481202) (← links)
• Evidence for genes controlling resistance to Heligmosomoides bakeri on mouse chromosome 1. (Q41673363) (← links)
• CD25high T cells with a prolonged survival inhibit development of diabetes (Q41872172) (← links)
• Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside (Q42569246) (← links)
• Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials (Q42676935) (← links)
• Oral anti‐CD3 monoclonal antibody delays diabetes in non‐obese diabetic (NOD) mice: effects on pregnancy and offspring—a preliminary report (Q51477188) (← links)
• Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis (Q51558970) (← links)
• Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice. (Q51786335) (← links)
• The association of variable number of tandem repeats of the insulin gene with susceptibility to type 1 diabetes among Korean subjects. (Q53465553) (← links)
• TCR transgenic mice reveal the impact of type 1 diabetes loci on early and late disease checkpoints. (Q53791154) (← links)
• Recent insights into CD4+T-cell specificity and function in Type 1 diabetes (Q58233277) (← links)
• Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice (Q61483536) (← links)
• Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity (Q64379536) (← links)
• T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors (Q91868488) (← links)